Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-17-008401
Filing Date
2017-09-13
Accepted
2017-09-13 09:13:16
Documents
35
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 PEAK PHARMACEUTICAL, INC. 10-Q peak_10q-17235.htm 10-Q 450405
2 SECTION 302 CERTIFICATION UNDER THE SARBANES-OXLEY ACT OF 2002 OF THE PRINCIPAL exhibit_31-1.htm EX-31.1 16737
3 SECTION 302 CERTIFICATION UNDER THE SARBANES-OXLEY ACT OF 2002 OF THE PRINCIPAL exhibit_31-2.htm EX-31.2 16456
4 SECTION 906 CERTIFICATION UNDER THE SARBANES-OXLEY ACT OF 2002 OF THE PRINCIPAL exhibit_32-1.htm EX-32.1 8399
5 SECTION 906 CERTIFICATION UNDER THE SARBANES-OXLEY ACT OF 2002 OF THE PRINCIPAL exhibit_32-2.htm EX-32.2 9382
  Complete submission text file 0001654954-17-008401.txt   1355203

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pkph-20170630.xml EX-101.INS 126158
7 XBRL TAXONOMY EXTENSION SCHEMA pkph-20170630.xsd EX-101.SCH 13567
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pkph-20170630_cal.xml EX-101.CAL 20826
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pkph-20170630_def.xml EX-101.DEF 27661
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pkph-20170630_lab.xml EX-101.LAB 107424
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pkph-20170630_pre.xml EX-101.PRE 80655
Mailing Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260
Business Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260 480.659.6404
PEAK PHARMACEUTICALS, INC. (Filer) CIK: 0001452804 (see all company filings)

EIN.: 261973257 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-53855 | Film No.: 171082323
SIC: 2834 Pharmaceutical Preparations